Cargando…

Patient innovation under rare diseases and chronic needs

Detalles Bibliográficos
Autores principales:	Oliveira, Pedro, Zejnilovic, Leid, Canhão, Helena, von Hippel, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249637/ http://dx.doi.org/10.1186/1750-1172-9-S1-O33

Ejemplares similares

Innovation by patients with rare diseases and chronic needs
por: Oliveira, Pedro, et al.
Publicado: (2015)

Peer Adoption and Development of Health Innovations by Patients: National Representative Study of 6204 Citizens
por: Oliveira, Pedro, et al.
Publicado: (2019)

Innovations Developed by Patients and Informal Caregivers for Needs Associated to Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2021)

Biotechnology clusters needs innovative minds and critical mass
por: Pinotti, Marcos, et al.
Publicado: (2014)

The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
por: Tambuyzer, Erik T, et al.
Publicado: (2014)

Ageing in rare, chronic diseases
por: Smit, Cees
Publicado: (2010)

Contribution of rare disease patient organisations to medical education
por: von Gizycki, Rainald
Publicado: (2010)

OA01 An innovative model for chronic pain management at the Evelina
por: Viegas, Megan, et al.
Publicado: (2022)

The German plan for rare diseases: a development in progress
por: Graf von der Schulenburg, Johann Mathias
Publicado: (2010)

OA04 Muscle weakness in chronic rheumatic diseases: the need for early diagnosis and tailored exercise programme
por: Rajeswaran, Thurkka, et al.
Publicado: (2023)

Editorial: Innovation in Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2022)

The sources of innovation
por: Von Hippel, Eric
Publicado: (1988)

The Swedish rare disease information database and the Swedish information centre for rare diseases
por: Greek-Winald, Christina, et al.
Publicado: (2010)

Science and innovation in malaria diagnostics
por: Krishna, Sanjeev
Publicado: (2014)

Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure
por: Lukačišinová, Anna, et al.
Publicado: (2015)

Determinants for research on rare diseases
por: Palau, Francesc
Publicado: (2010)

RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases
por: Taruscio, D, et al.
Publicado: (2014)

P080 Comparison of efficacy of innovator molecule of itraconazole with generic forms of itraconazole in treatment naïve subjects with chronic pulmonary aspergillosis
por: Sehgal, Inderpaul, et al.
Publicado: (2022)

French experience with rare diseases plans
por: Le Henanff, Guillaume, et al.
Publicado: (2010)

Which support from the French Foundation of rare disease towards clinical trial set up in rare diseases?
por: Ravagnan, Luigi
Publicado: (2015)

The added value of centres of expertise for rare disease patients in Europe
por: Kole, Anna A, et al.
Publicado: (2010)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

Recommendations for the development of national plans for rare diseases
por: Van der Zeijden, Albert, et al.
Publicado: (2010)

Innovation Process Benefits: The Journey as Reward
por: von Hippel, Eric
Publicado: (2013)

OrphanAnesthesia – anesthesia recommendations for patients suffering from rare diseases
por: Münster, Tino
Publicado: (2014)

Brazilian biotechnology network - the challenge to innovate in biotechnology in Brazil
por: de Castro, Luiz Antonio Barreto
Publicado: (2014)

Towards a European platform for Rare Diseases Registries
por: Nicholl, Ciarán
Publicado: (2014)

National Rare Disease Registries: overview from Spain
por: de la Paz, M Posada, et al.
Publicado: (2014)

The European Union Committee of Experts on Rare Diseases (EUCERD): a new committee to help the European Commission advance in the field of rare disease policy
por: Moliner, Antoni Montserrat, et al.
Publicado: (2010)

The present situation of Rare Diseases in Central/Eastern Europe? The role of patient organisations
por: Pogany, Gabor
Publicado: (2010)

Classification of rare diseases: a worldwide effort to contribute to the International Classification of Diseases
por: Rath, Ana, et al.
Publicado: (2010)

Effectiveness of an innovative community-based breast cancer awareness workshop
por: Al-Shammari, A, et al.
Publicado: (2012)

Use of animal models for exome prioritization of rare disease genes
por: Smedley, Damian, et al.
Publicado: (2014)

Health needs assessment of musculoskeletal conditions: an international bone and joint burden of disease study
por: Khaltaev, N, et al.
Publicado: (2004)

O39c. An innovative device for objective hand disinfection control
por: Haidegger, T, et al.
Publicado: (2011)

The SolarMal Project: innovative mosquito trapping technology for malaria control
por: Hiscox, Alexandra, et al.
Publicado: (2012)

The role of an in-house audit group as an innovative tool to review clinical trials
por: Trivedi, Shivali, et al.
Publicado: (2015)

Tailoring study design to each stage of surgical innovation: the ideal recommendations
por: Hirst, Allison, et al.
Publicado: (2013)

13 Innovative Strategies for Managing Swine Welfare During Natural Disasters
por: Johnson, Anna K, et al.
Publicado: (2021)

Knowledge on malignant hyperthermia: as rare as the disease? A nation wide survey
por: Wolvetang, Timothy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7dtjriqbvqdiq94o3d00o6u0t4